ÂÜÀòÂÒÂ×

Bernt has 30 years of experience in commercially introducing new medical technologies for improved precision in radiotherapy. Stereotactic neurosurgery, image-guided surgery, stereotactic radiosurgery, 3D treatment planning, IMRT, proton therapy and light ions therapy are technologies he has introduced to world markets. He currently serves as chairman of Lioness Therapeutics AB in Sweden and interim VP of Lioness Light Ions. Bernt’s degree is from the Stockholm School of Economics.